Search Results - "metastasis"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    VEGF inhibitors for anti-angiogenic therapy

    Published 2007
    Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
    Get full text
    Series
    Electronic Video
  2. 2

    VEGF inhibitors for anti-angiogenic therapy

    Published 2007
    Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
    Get full text
    Series
    Electronic Video
  3. 3

    VEGF inhibitors for anti-angiogenic therapy

    Published 2007
    Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
    Get full text
    Series
    Electronic Video
  4. 4

    VEGF inhibitors for anti-angiogenic therapy

    Published 2007
    Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
    Get full text
    Series
    Electronic Video
  5. 5

    VEGF inhibitors for anti-angiogenic therapy

    Published 2007
    Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
    Get full text
    Series
    Electronic Video
  6. 6

    VEGF inhibitors for anti-angiogenic therapy

    Published 2007
    Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
    Get full text
    Series
    Electronic Video